Literature DB >> 9918848

Cleavage of RXRalpha by a lysosomal enzyme, cathepsin L-type protease.

Y Nomura1, T Nagaya, S Yamaguchi, N Katunuma, H Seo.   

Abstract

In this study, we characterized a protease responsible for the cleavage of RXRalpha in two human derived cell lines, HepG2 and JEG-3 cells. Electrophoretic mobility shift assay (EMSA) combined with antibody supershift analysis suggested that contamination of cytoplasmic components during nuclear extract preparation could result in complete cleavage of RXRalpha at its N-terminus in JEG-3 cells, while such proteolytic activity was much less evident in HepG2. When the nuclei were purified in the presence of leupeptin, only full-length RXRalpha was found in the extracts prepared from both JEG-3 and HepG2 cells, suggesting a member of cysteine protease family is responsible for the cleavage. The presence of the protease in the cytoplasm, but not in the nucleus, was confirmed by incubating full-length 35S-labeled RXRalpha with each fraction. The cytoplasmic fraction from JEG-3 and HepG2 cells cleaved RXRalpha into smaller sizes with molecular mass of 45, 43, and 31 kD. Immunoprecipitation with antibodies recognizing distinct epitopes indicated that the cleaved RXRalpha with the size of 45 and 43 kD were truncated at N-terminus in which most of the A/B domain was absent. Using a series of protease inhibitors, the enzyme cleaving RXRalpha was characterized as cathepsin L-type protease. The enzyme activity in JEG-3 cells was much higher than that in HepG2 cells. This is the first demonstration that RXRalpha is cleaved by a lysosomal enzyme, cathepsin L-type protease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918848     DOI: 10.1006/bbrc.1998.9941

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.

Authors:  Hu Zhou; Wen Liu; Ying Su; Zhen Wei; Jie Liu; Siva Kumar Kolluri; Hua Wu; Yu Cao; Jiebo Chen; Yin Wu; Tingdong Yan; Xihua Cao; Weiwei Gao; Andrei Molotkov; Fuquan Jiang; Wen-Gang Li; Bingzhen Lin; Hai-Ping Zhang; Jinghua Yu; Shi-Peng Luo; Jin-Zhang Zeng; Gregg Duester; Pei-Qiang Huang; Xiao-Kun Zhang
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

Review 2.  Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites.

Authors:  Xiao-kun Zhang; Ying Su; Liqun Chen; Fan Chen; Jie Liu; Hu Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-12-01       Impact factor: 6.150

Review 3.  Targeting truncated RXRα for cancer therapy.

Authors:  Xiaokun Zhang; Hu Zhou; Ying Su
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-10-21       Impact factor: 3.848

4.  Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.

Authors:  Guang-Hui Wang; Fu-Quan Jiang; Ying-Hui Duan; Zhi-Ping Zeng; Fan Chen; Yi Dai; Jie-Bo Chen; Jin-Xing Liu; Jie Liu; Hu Zhou; Hai-Feng Chen; Jin-Zhang Zeng; Ying Su; Xin-Sheng Yao; Xiao-Kun Zhang
Journal:  Cancer Res       Date:  2012-11-14       Impact factor: 12.701

5.  A unique cytoplasmic localization of retinoic acid receptor-gamma and its regulations.

Authors:  Young-Hoon Han; Hu Zhou; Jin-Hee Kim; Ting-dong Yan; Kee-Ho Lee; Hua Wu; Feng Lin; Na Lu; Jie Liu; Jin-zhang Zeng; Xiao-kun Zhang
Journal:  J Biol Chem       Date:  2009-05-05       Impact factor: 5.157

6.  Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.

Authors:  Na Lu; Jinxing Liu; Jie Liu; Chunyun Zhang; Fuquan Jiang; Hua Wu; Liqun Chen; Wenjun Zeng; Xihua Cao; Tingdong Yan; Guanghui Wang; Hu Zhou; Bingzhen Lin; Xiaomei Yan; Xiao-kun Zhang; Jin-Zhang Zeng
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

7.  NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell.

Authors:  Fan Chen; Jiebo Chen; Jiacheng Lin; Anton V Cheltsov; Lin Xu; Ya Chen; Zhiping Zeng; Liqun Chen; Mingfeng Huang; Mengjie Hu; Xiaohong Ye; Yuqi Zhou; Guanghui Wang; Ying Su; Long Zhang; Fangfang Zhou; Xiao-Kun Zhang; Hu Zhou
Journal:  Protein Cell       Date:  2015-07-09       Impact factor: 14.870

8.  Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.

Authors:  Liqun Chen; Alexander E Aleshin; Gulimiran Alitongbieke; Yuqi Zhou; Xindao Zhang; Xiaohong Ye; Mengjie Hu; Gaoang Ren; Ziwen Chen; Yue Ma; Duo Zhang; Shuai Liu; Weiwei Gao; Lijun Cai; Lingjuan Wu; Zhiping Zeng; Fuquan Jiang; Jie Liu; Hu Zhou; Gregory Cadwell; Robert C Liddington; Ying Su; Xiao-Kun Zhang
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

Review 9.  Overview of the structure-based non-genomic effects of the nuclear receptor RXRα.

Authors:  Liqun Chen; Lingjuan Wu; Linyan Zhu; Yiyi Zhao
Journal:  Cell Mol Biol Lett       Date:  2018-08-07       Impact factor: 5.787

10.  Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.

Authors:  Xiaohong Ye; Hua Wu; Luoyan Sheng; Yi-Xin Liu; Fang Ye; Mo Wang; Hu Zhou; Ying Su; Xiao-Kun Zhang
Journal:  Nat Commun       Date:  2019-04-01       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.